Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 21, 2019; 25(3): 330-345
Published online Jan 21, 2019. doi: 10.3748/wjg.v25.i3.330
Published online Jan 21, 2019. doi: 10.3748/wjg.v25.i3.330
Figure 6 Schematic model of the role of NKX6.
3 in gastric mucosal atrophy. In gastric mucosal cells, NKX6.3 prevents gastric mucosal atrophy by regulating amyloid β (Aβ) peptide accumulation and oligomerization through inhibiting the γ-secretase complex formation and the expression of apolipoprotein E (ApoE), and β-secretase 1. In addition, NKX6.3 suppresses gastric mucosal inflammation by modulating ApoE-induced nuclear factor kappa B activity and expression of cytokines. Aβ: Amyloid β; ApoE: Apolipoprotein E; Bace1: β-secretase 1; NF-κB: Nuclear factor kappa B.
- Citation: Yoon JH, Lee YS, Kim O, Ashktorab H, Smoot DT, Nam SW, Park WS. NKX6.3 protects against gastric mucosal atrophy by downregulating β-amyloid production. World J Gastroenterol 2019; 25(3): 330-345
- URL: https://www.wjgnet.com/1007-9327/full/v25/i3/330.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i3.330